Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19

14 Sept 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32941953
DOI: 10.1016/j.gene.2020.145145

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19PMID 32941953Read ↗

Interleukin-6 as a potential biomarker of COVID-19 progressionSemantic proximity Read ↗

Stages or phenotypes? A critical look at COVID-19 pathophysiologySemantic proximity Read ↗

Risk Factors for In-hospital Progression of Ordinary COVID-19 in Wuhan, China: A Retrospective Cohort StudySemantic proximity Read ↗

COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by TLR7 gene polymorphism (rs3853839) in middle-aged individuals without previous comorbiditiesSemantic proximity Read ↗

Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19Semantic proximity Read ↗

POST-COVID-19 SYNDROME, INFLAMMATORY MARKERS AND SEX DIFFERENCESSemantic proximity Read ↗

Correlating COVID-19 severity with biomarker profiles and patient prognosisSemantic proximity Read ↗

Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19Semantic proximity Read ↗

COVID-19-neutralizing antibodies predict disease severity and survivalSemantic proximity Read ↗

Impact of IL-6 rs1800795 and IL-17A rs2275913 gene polymorphisms on the COVID-19 prognosis and susceptibility in a sample of Iranian patients.Semantic proximity Read ↗

Increased Pro Th1 And Th17 Transcriptional Activity In Patients With Severe COVID-19Semantic proximity Read ↗

Inflammation Patterns in Omicron Variant-Linked COVID-19: Assessing Biomarkers for Predicting Disease SeveritySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.